Authors
Latest:
UNCOVERING HIDDEN PREDATORS IN DISEASEThis article is produced by Roche for healthcare professionals and is not intended to provide medical advice and/or treatment guidance. This website is not country-specific and therefore may contain information which is not applicable to your country.
Latest:
Maintaining quality and safety in retina clinics during a pandemicTo maintain treatment quality and patient and staff safety in the SARS-CoV-2 era, it is important to minimise clinic visits and maximise use of imaging modalities. In addition, extending treatment intervals with longer-acting agents is key to maximising safety and patients’ vision outcomes.
Latest:
Cataract predictability: Screen and treat unstable tear film in weeksCorrecting abnormal tear film osmolarity before cataract surgery enables more accurate measurements to be captured, reducing residual refractive error.
Latest:
Assessing the quality of real-world evidence in retinal diseasesA recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Latest:
French OPHTAMYOP study reveals trends in myopia controlHow studies into myopia management can increase access to vision care
Latest:
New therapeutic targets, drug development for retinitis pigmentosaSimply slowing disease progression is no longer enough
Latest:
What innovation means for the treatment of corneal dystrophiesPhysician outlines latest emerging technologies to treat condition
Latest:
Fortified antibiotic advance improves corneal infection treatment paradigmNo two corneal ulcers are alike, but if they are large and centrally located, the common denominator is that time is of the essence
Latest:
Tried and tested therapeutic options for meibomian gland dysfunctionMethods using a combination of non-invasive thermal treatments and meibomian gland expression seem to be particularly effective.
Latest:
Amblyopia screening with the dynamic random dot stereotestA new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.
Latest:
Retinal imaging to detect Alzheimer disease: machine learning modelAn interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.
Latest:
No toric? No problem: Small-aperture optics can mitigate astigmatismA one-piece, hydrophobic, monofocal IOL uses the small-aperture concept to provide a good alternative to the toric IOLs currently available.
Latest:
Study examines pairing phacoemulsification with implantation of stentsA cost-utility analysis found that concurrent phacoemulsification and minimally invasive glaucoma surgery using trabecular microbypass stents is cost-effective for treating mild to moderate open-angle glaucoma, compared with cataract surgery alone.
Latest:
Monitoring glaucoma progression rate to preserve patients’ visionThree approaches to examination give a comprehensive overview
Latest:
Magnetic cell therapy for corneal endothelial dysfunctionPhase 1 multicentre study data demonstrate early signs of efficacy
Latest:
Artificial intelligence for the early detection of ectatic corneal diseasesOne of AI’s most promising applications: new diagnostic algorithms
Latest:
Retinal imaging to detect Alzheimer disease: machine learning modelAn interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.
Latest:
Going for gold: The new standard for cross-linkingStabilising keratoconus and improving vision using ELZA-PACE customised CXL
Latest:
The future of microbial keratitis treatment is brightUltraviolet light’s potential in ocular care extends beyond structural reinforcement to antimicrobial applications, especially for microbial keratitis
Latest:
Intravenous bevacizumab repackaged for intravitreal use: Making the sight-saving treatment saferAlthough off-label repackaged bevacizumab syringes appear to satisfy an urgent clinical and financial need for patients with a variety of retinal disorders, they are known to be associated with considerable public health concerns due to the risks posed to patients from compounding pharmacies’ lack of compliance with a variety of FDA requirements.
Latest:
ARVO 2025: Ocular and systemic mitochondrial diseases may be key to dementia diagnosisDetecting mitochondrial dysfunction may give clinicians a chance to reduce the rate of cognitive decline in patients with dementia
Latest:
In 2024, data-driven tools will shape cataract and refractive surgeryWorking smarter, not harder, to benefit patients
Latest:
Assessing the quality of real-world evidence in retinal diseasesA recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Latest:
Novel therapies emerge for a progressive corneal diseaseCurrent and future options for Fuchs endothelial corneal dystrophy
Latest:
Toric IOLs for beginners: What to consider before and during surgery and in the postoperative periodGiving due consideration to preoperative marking and the surgical technique in toric IOL implantation, as well as being diligent about reviewing postoperative results, can improve patient outcomes whilst minimising the chance of errors.
